Search
for
Sort by
Research 391–420 of 476
- PRP for Immune Mediated Alopecias (Alopecia Areata, Alopecia Totalis)
- High throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in Alopecia Areata
- New Modalities in the Treatment of Refractory Alopecia Areata
- Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital
- Role of Aire and Notch4 Allelic Mutations in Alopecia Areata in C3H/HeJ Mice
- Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy
- Approach to Managing Recalcitrant Alopecia Areata with Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Alopecia Areata in Sub-Saharan Africa: A Scoping Review Protocol on Epidemiology, Clinical Presentation, Burden, Treatment, and Evidence Gaps.
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Decoding Gut Microbiome Dysbiosis as a Non-Invasive Diagnostic Biomarker for Alopecia Areata
- T <sub>H</sub> 1 effector CD4 T cells rely on IFN-γ production to induce alopecia areata
- Evaluation of the efficacy of topical metformin 10% and 20% versus topical potent steroid in the treatment of patients with alopecia areata
- Rapidly Progressive Alopecia Universalis after Varicella-Zoster Virus Infection: The role of Immune Dysregulation and Tofacitinib treatment
- Unveiling the immune and vitamin profiles of blood: the potential biomarkers for alopecia areata
- Efficacy and safety of tofacitinib in patients with total and universal alopecia- A retrospective evaluation of 69 patients
- Alopecia areata treated using CO2 fractional laser with different parameters
- The Role of Minoxidil in Treatment of Alopecia Areata: A Systematic Review and Meta-Analysis
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Refractory Myasthenia Gravis and Concurrent Alopecia Areata Postthymectomy With Improvements After Cortisone Taper: A Case Report
- Upadacitinib for the treatment of alopecia areata – A case report
- 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata
- 27 Preclinical ex vivo and in vivo evidence supporting selective inhibition of tyrosine kinase 2-dependent, IL-12-mediated signaling as a novel pharmacological strategy for alopecia areata management
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)
- 1406 Environmental pathobiology of frontal fibrosing alopecia (FFA): A link between linalool sensitization and FFA development
- 382 Environmental pathobiology of frontal fibrosing alopecia (FFA): Does linalool promote FFA development and progression by inducing epithelial hair follicle stem cell damage and MICA expression in the bulge?
- 004 Cell-based therapy may be effective in alopecia areata: Preclinical evidence that autologous, peripheral regulatory γdT cells are preventive in human ex vivo and therapeutic in human in vivo models
- ESDR382 - Environmental pathobiology of frontal fibrosing alopecia (FFA): Does linalool promote FFA development and progression by inducing epithelial hair follicle stem cell damage and MICA expression in the bulge?
- Effects of biomaterials derived from germinated hemp seeds for stressed hair stem cells and immune cells
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Pharmacologic inhibition of JAK-STAT signaling promotes hair growth